Our ThyroSeq® Patient Access Program is to ensure that all of the patients and physicians we serve have access to ThyroSeq®, regardless of insurance coverage or income.
Medicare typically covers your Thyroid FNA except for a small co-insurance. There is no other out-of-pocket expense for the ThyroSeq® test.
Insurance companies often cover your thyroid FNA and ThyroSeq. Based on your eligibility and benefits, you may be responsible for an annual deductible, co-insurance and/or copayment as indicated on your explanation of benefits. You may contact your insurance company directly and provide CPT code 0026U to determine an estimate of your out-of-pocket expense.
Financial assistance is available to ensure that this valuable test is available to any patient that can medically benefit from the results.
ThyroSeq® Test is Cost-Effective
Now, perhaps more than ever in recent history, reducing costs for patients, clinicians, and insurers is vital.
As per the results of a recent study, which used a decision tree model to compare the cost-effectiveness of diagnostic lobectomy, and ThyroSeq GC for Bethesda III/IV thyroid nodules, ThyroSeq GC testing is the most cost-effective choice, with the highest likelihood of directing the correct clinical management.*